Cardiome Pharma Corp. may need to retest the $4.60 lows
Given the selling momentum we may have to retest the lows at $4.60 before we get some buying conviction.
March 14, 2011 | Posted in Pharmaceuticals | Read Article »
Category archives for:
Pharmaceuticals
New Sheriff arrives at Biovail
Looking at the value of the stock since the announcement of the merger with Valeant Pharmaceuticals International (VRX TSX) I think the short term good news is already baked into this pie and its about execution of their plan as we go forward.
July 7, 2010 | Posted in Pharmaceuticals | Read Article »
Cardiome Pharma hitting resistance at $9.00
Before you commit new money to your existing position in COM let it make a sustained break above $9.00 and watch for continued support at $8.00 so that you hold onto the profits you have already earned.
May 31, 2010 | Posted in Pharmaceuticals | Read Article »
Mind the gap
As far as your question of pumping and dumping in the stock I can’t say but its clear that there are a number of other issues that need to be recognized and managed if you are going to hunt in this gap.
May 14, 2010 | Posted in Pharmaceuticals | Read Article »
FXA has caught a cold
I think that the market has the story on FXA. It’s a stock that has enjoyed a nice run but investors are not convinced that it can maintain the sales increases that are seen to driven by one time events.
April 14, 2010 | Posted in Pharmaceuticals | Read Article »
Maybe but not now
Currently the stock is trading below the 50 and 200 day moving averages and is currently in a downtrend.
March 24, 2010 | Posted in Pharmaceuticals | Read Article »
Not so nu
NCS has developed wound dressings that are coated with nanoparticles of silver to accelerate the healing process.
October 26, 2009 | Posted in Pharmaceuticals | Read Article »
